We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+64.46%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$660M
AUM Growth
+$82M
(+14%)
Cap. Flow
-$67.4M
Cap. Flow
% of AUM
-10.21%
Top 10 Holdings %
Top 10 Hldgs %
11.44%
Holding
365
New
119
Increased
40
Reduced
61
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fabrinet
FN
|
+$6.43M |
| 2 |
Badger Meter
BMI
|
+$5.31M |
| 3 |
Dycom Industries
DY
|
+$5.05M |
| 4 |
Watts Water Technologies
WTS
|
+$4.99M |
| 5 |
Advanced Energy
AEIS
|
+$4.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$6.55M |
| 2 |
Doximity
DOCS
|
+$6M |
| 3 |
Alkermes
ALKS
|
+$5.25M |
| 4 |
Axsome Therapeutics
AXSM
|
+$4.92M |
| 5 |
Alignment Healthcare
ALHC
|
+$4.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.63% |
| 2 | Technology | 25.32% |
| 3 | Healthcare | 14.14% |
| 4 | Financials | 8.88% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Antero Midstream
AM
$10.2B
| $4.09M | 0.62% |
+215,827
| New | +$3.86M |
|
|
VISN
77
Vistance Networks Inc
VISN
$2.78B
| $4.01M | 0.61% |
+484,027
| New | +$2.53M |
|
78
JFrog
FROG
$10.4B
| $3.99M | 0.6% |
+90,869
| New | +$3.45M |
|
79
Protagonist Therapeutics
PTGX
$8.8B
| $3.98M | 0.6% |
71,971
+2,790
| +4% | +$134K |
|
80
Pricesmart
PSMT
$5.99B
| $3.95M | 0.6% |
+37,589
| New | +$3.79M |
|
81
Lincoln Educational Services
LINC
$1.4B
| $3.92M | 0.59% |
170,103
+121,183
| +248% | +$2.43M |
|
82
Willdan Group
WLDN
$1.14B
| $3.85M | 0.58% |
+61,614
| New | +$2.94M |
|
83
Palomar
PLMR
$3.59B
| $3.82M | 0.58% |
24,768
-10,932
| -31% | -$1.69M |
|
84
BridgeBio Pharma
BBIO
$16.1B
| $3.76M | 0.57% |
87,166
-26,104
| -23% | -$949K |
|
85
Adaptive Biotechnologies
ADPT
$3.96B
| $3.75M | 0.57% |
+321,573
| New | +$2.92M |
|
|
KRMN
86
Karman Holdings
KRMN
$7.27B
| $3.68M | 0.56% |
+72,989
| New | +$2.94M |
|
|
AAMI
87
Acadian Asset Management
AAMI
$3.27B
| $3.67M | 0.56% |
+104,132
| New | +$3.03M |
|
88
HCI Group
HCI
$2.29B
| $3.62M | 0.55% |
23,813
-3,448
| -13% | -$529K |
|
89
Comstock Resources
CRK
$3.83B
| $3.6M | 0.55% |
130,104
-25,916
| -17% | -$590K |
|
|
SLNO
90
DELISTED
Soleno Therapeutics
SLNO
| $3.58M | 0.54% |
42,741
-6,807
| -14% | -$509K |
|
91
Innodata
INOD
$2.28B
| $3.58M | 0.54% |
69,870
-5,035
| -7% | -$199K |
|
92
Amer Sports
AS
$21.4B
| $3.55M | 0.54% |
91,471
-20,168
| -18% | -$620K |
|
93
Grand Canyon Education
LOPE
$3.96B
| $3.53M | 0.53% |
18,655
-2,850
| -13% | -$528K |
|
94
Pitney Bowes
PBI
$2.51B
| $3.48M | 0.53% |
319,245
-47,195
| -13% | -$444K |
|
95
AvePoint
AVPT
$2.87B
| $3.47M | 0.53% |
179,665
+7,005
| +4% | +$121K |
|
96
Ouster
OUST
$3.11B
| $3.43M | 0.52% |
+141,618
| New | +$1.72M |
|
|
CDTX
97
DELISTED
Cidara Therapeutics
CDTX
| $3.4M | 0.52% |
+69,902
| New | +$1.68M |
|
98
Archer Aviation
ACHR
$3.97B
| $3.35M | 0.51% |
309,146
+115,035
| +59% | +$1.08M |
|
99
American Healthcare REIT
AHR
$10.7B
| $3.33M | 0.5% |
90,734
-27,984
| -24% | -$930K |
|
100
Healthcare Services Group
HCSG
$1.58B
| $3.33M | 0.5% |
+221,466
| New | +$2.94M |
|
Similar funds
RWM
MCM
HP
OMG
RB
ICCFIA
WFAL
WCM
EAM Investors's Q2 2025 Portfolio in Review
As of Q2 2025, EAM Investors held 365 positions worth $660M, up 14% from $578M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $67.4M in Q2 2025, closing 145 positions and reducing 61 holdings. Its most notable exit was EXL Service, an estimated $6.55M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 8.7% a quarter earlier, followed by Technology and Healthcare.
Against the trend, EAM Investors opened a new position in Fabrinet worth $8.51M.
- EAM Investors's largest Q2 2025 buy was Fabrinet: 28,875 shares worth $8.51M.
- EAM Investors added most to Limbach Holdings in Q2 2025, an estimated $4.06M increase.
- EAM Investors's biggest Q2 2025 reduction was AngioDynamics, cutting an estimated $2.84M.
- EAM Investors fully exited EXL Service in Q2 2025, selling an estimated $6.55M.
- EAM Investors's ten largest holdings make up 11% of its $660M portfolio in Q2 2025.
- EAM Investors opened 119 new positions and closed 145 in Q2 2025.
- EAM Investors's portfolio value rose 14% quarter-over-quarter to $660M.
Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.